Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults.
about
Treating refractory leukemias in childhood, role of clofarabineOsteosarcoma: Current Treatment and a Collaborative Pathway to SuccessEfficacy and safety of ifosfamide-based chemotherapy for osteosarcoma: a meta-analysisNephrotoxicity after ifosfamideNeoadjuvant and adjuvant chemotherapy with doxorubicin and ifosfamide for bone sarcomas in adult and older patientsTreatment pathway of bone sarcoma in children, adolescents, and young adultsRelevance of historical therapeutic approaches to the contemporary treatment of pediatric solid tumors.Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology GroupMetastatic Ewing's sarcoma/PNET of kidney in 40 year old patientRare non-Wilms' tumors in childrenIfosfamide/etoposide alternating with high-dose methotrexate: evaluation of a chemotherapy regimen for poor-risk osteosarcomaPrognostic impact of chromosomal aberrations in Ewing tumoursBaseline and early lymphopenia predict for the risk of febrile neutropenia after chemotherapyIntensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group.Outcome and toxicity of an Ifosfamide-based soft tissue sarcoma treatment protocol in children. The importance of local therapy.Management of advanced adult soft tissue sarcoma.Biomarkers in Ewing Sarcoma: The Promise and Challenge of Personalized Medicine. A Report from the Children's Oncology Group.Lung metastasis of primary alveolar soft-part sarcoma occurring 20 years after initial treatment.Pharmacotherapy of sarcoma.Mifamurtide for the treatment of nonmetastatic osteosarcomaChemotherapy for osteosarcoma - where does it come from? What is it? Where is it going?Metastatic osteosarcoma: a challenging multidisciplinary treatment.Oligoclonality and new agent evaluation in acute lymphoblastic leukaemia.A dose-intensive, cyclophosphamide-based regimen for the treatment of recurrent/progressive or advanced solid tumors of childhood: a report from the Australia and New Zealand Children's Cancer Study Group.Relapse after localized rhabdomyosarcoma: Evaluation of the efficacy of second-line chemotherapy.Alveolar soft-part sarcoma of the extremity: a case report.Metastatic extraosseous Ewing's sarcoma (EES)/primitive neuroectodermal tumor (PNET) of the kidney: 8-year durable response after induction and maintenance chemotherapy.Predictive factors of histological response to primary chemotherapy in Ewing's sarcoma.Ewing's sarcoma: experience with 12 cases.Efficacy of ifosfamide and doxorubicin given as a phase II "window" in children with newly diagnosed metastatic rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study Group.Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas.Chronic neuroblastoma.Primary pulmonary synovial sarcoma: a rare primary pulmonary tumor.Treatment with recombinant human erythropoietin in children with malignancies.Progress in the chemotherapeutic treatment of osteosarcoma
P2860
Q24647279-1799E62F-AE97-4D4C-BBEF-3EC85AD1E647Q26797555-1B69FD1F-51E0-44A0-86E3-4BC9A56AE795Q28084433-C2A22A6F-FF35-4EAE-B447-7111E7FA2F9CQ28335826-797E9C8F-0648-4358-B566-EF724396D700Q33418510-35851DF2-96E0-4CBB-9EA8-A97C691F615BQ33835657-EE1C8803-4760-4006-937D-D72DD3396A8EQ34589401-4AD9303B-27F8-4637-B8D0-E91B5D495AA2Q35615792-B7DC3A68-A870-433E-89BA-715F5C5BE45EQ35884342-14246242-43C9-4B27-BFFD-429B83855780Q35887414-B2209BD2-E082-4ED0-9CEF-54CAB0D154F6Q36617611-A5D3255F-216C-4491-898B-4375D2CE3B65Q36644524-B9A4A2B9-4D5C-4144-92DE-9BBE41D13907Q36648720-FD46600B-87D8-428D-91B6-22C838BDE4A3Q36653789-22268F16-C580-4CA9-826F-D6D9B8A4ACBAQ36673933-2B717DBF-05FC-48D5-A0C7-3D5DE42791FDQ36674228-319F3A30-2059-4D04-B090-A8F0C39996BEQ36907188-D34AAF20-E4F3-4F52-919A-8E06319AE954Q37385760-7194BFFE-9B85-452D-8DE8-B9BC0BC851B4Q37532566-F53069CD-7C0F-482D-A7C5-DC6732F8747BQ37827876-0904A607-D42D-4F00-8140-EAF46A088EE4Q38126943-EDCF5397-2BB8-4840-9848-3C498958C8AFQ38783252-1EEAAE48-50C5-4F60-9B20-A71A463B4765Q38843371-43C24569-1186-448B-A8E8-FF8A3CB52455Q41548732-0B4F04AD-DC5D-43C5-BB0B-31C29FC852F0Q41607004-26C9CEA2-14BF-4300-83AE-7EAC6D555229Q42063446-AE057C67-0F78-43CB-A2BF-45A50CD7668AQ42767609-3417CC20-674E-4D9C-BC07-A9122FCCD181Q43699064-CE082E30-48DD-458D-90CC-C574E24DD14CQ43749837-14B28647-C46E-489E-8FE6-8431BB7276E1Q43824897-4B25F3C0-AE3E-4895-BC08-1D4CC962C02BQ44128427-EA3F4DBD-318D-4362-9E65-338D1F82E9DDQ44128430-74341047-F0A0-4FAA-A0BB-C9B253AC2972Q44267828-68DFD3A6-EBC8-4BD9-A755-8C5D96B4A0B1Q51021337-FDB6E06C-05B7-4CC8-AA80-BB620560C678Q58572917-83EF58A6-0B89-42BA-8F66-23A363D1BDB4
P2860
Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults.
description
1987 nî lūn-bûn
@nan
1987 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Ifosfamide with mesna uroprote ...... of children and young adults.
@ast
Ifosfamide with mesna uroprote ...... of children and young adults.
@en
type
label
Ifosfamide with mesna uroprote ...... of children and young adults.
@ast
Ifosfamide with mesna uroprote ...... of children and young adults.
@en
prefLabel
Ifosfamide with mesna uroprote ...... of children and young adults.
@ast
Ifosfamide with mesna uroprote ...... of children and young adults.
@en
P2093
P1476
Ifosfamide with mesna uroprote ...... of children and young adults.
@en
P2093
P Jarosinski
T J Kinsella
T J Triche
P304
P356
10.1200/JCO.1987.5.8.1191
P407
P577
1987-08-01T00:00:00Z